Chronic and prolonged exposure to antigens in cancer leads to increased expression of CTLA-4 and PD-1 resulting in acquired tolerance of antigens, thus nullifying effector functions such as cytokine production, cytotoxicity, and T cell proliferation. The gene discussed is PDCD1; the disease is cancer.